ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE does not recommend Janssen’s multiple myeloma drug
europeanpharmaceuticalreview
March 30, 2017The National Institute for Health and Care Excellence (NICE) has published new draft guidance not recommending daratumumab monotherapy (Darzalex, Janssen) to treat some people with multiple myeloma.
Pharma Sources Insight January 2025
